Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference32 articles.
1. US Department of Health and Human Services. Requirements on content and format of labeling for human prescription drug and biological products. 21 CFR §201.56. https://www.gpo.gov/fdsys/granule/CFR-2012-title21-vol4/CFR-2012-title21-vol4-sec201-56. Effective April 1, 2012. Accessed February 20, 2018.
2. Lindstrom J. Sources of drug information: FDA-approved labeling and other official FDA sources. Dermatol Ther. 2009;22:246–256.
3. Greene SM, Noah L. Debate: Off-label drug promotion and the first amendment. Univ PA Law Rev. 2015;62:239–267.
4. Pfister DG. Off-label use of oncology drugs: the need for more data and then some. J Clin Oncol. 2012;30:584–586.
5. Soares M. “Off-label” indications for oncology drug use and drug compendia: history and current status. J Oncol Pract. 2005;1:102–105.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献